Author:
Nutt D. J.,Peill J. M.,Weiss B.,Godfrey K.,Carhart-Harris R. L.,Erritzoe D.
Publisher
Springer Berlin Heidelberg
Reference134 articles.
1. Abuse S (2021) Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56)
2. Adamson S, Metzner R (1988) The nature of the MDMA experience and its role in healing, psychotherapy and spiritual practice. Revision 10(4):59–72
3. Aday JS, Davis AK, Mitzkovitz CM, Bloesch EK, Davoli CC (2021) Predicting reactions to psychedelic drugs: a systematic review of states and traits related to acute drug effects. ACS Pharmacol Transl Sci 4(2):424–435
4. Aday JS, Heifets BD, Pratscher SD, Bradley E, Rosen R, Woolley JD (2022) Great expectations: recommendations for improving the methodological rigor of psychedelic clinical trials. Psychopharmacology (Berl):1–22
5. Agin-Liebes G, Zeifman R, Luoma JB, Garland EL, Campbell WK, Weiss B (2022) Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca. J Psychopharmacol 36(3):295–308